Medtronic's shares have sharply rallied over the last six months. The medtech giant's growth catalysts include a best-in-class product (Affera) in a fast-growing $11 billion space and a massive ...

Medtronic's diabetes care unit has grown faster than the rest of its business in recent years. However, the company decided to spin off this segment into a stand-alone corporation. Still, Medtronic ...

A federal jury ordered Medtronic to hand a competitor about $382 million after ruling the Minnesota-run medtech company violated anti-monopoly laws by selling technology to hospitals with unlawfully ...

Medtronic is a large medical device company with a strong history of returning value to shareholders. It has a 3.25% dividend yield and an attractive valuation. Medtronic is taking important steps to ...